bendamustine hydrochloride has been researched along with Pyrexia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Mon, M; Antolin-Amerigo, D; Barbarroja-Escudero, J; Rodriguez-Rodriguez, M; Sanchez-Gonzalez, MJ | 1 |
| Awan, FT; Byrd, JC; Eisenfeld, AJ; Garcia-Marco, JA; Hallek, M; Hebart, H; Hellmann, A; Hill, BT; Jaeger, U; Kloczko, J; Lech-Maranda, E; Loscertales, J; Mato, A; Pagel, JM; Robak, T; Stromatt, SC | 1 |
| Aldaoud, A; Becker, M; Del Giudice, I; Fricke, HJ; Gercheva, L; Goranov, S; Herbrecht, R; Huguet, F; Juliusson, G; Klein, P; Knauf, WU; Liberati, A; Lissichkov, T; Loscertales, J; Merkle, K; Montillo, M; Postner, G; Tremmel, L | 1 |
| Grünwald, V; Hartmann, JT; Horger, M; Huober, J; Käfer, G; Kanz, L; Mayer, F; Meisinger, I; Pintoffl, J; Schleicher, J | 1 |
3 trial(s) available for bendamustine hydrochloride and Pyrexia
| Article | Year |
|---|---|
Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Disease-Free Survival; Drug Administration Schedule; Female; Fever; Humans; Immunoglobulin G; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neutropenia; Recombinant Fusion Proteins; Recurrence; Remission Induction; Salvage Therapy | 2017 |
Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia.
Topics: Adult; Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Chlorambucil; Disease-Free Survival; Female; Fever; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nausea; Neutropenia; Nitrogen Mustard Compounds; Thrombocytopenia; Time Factors; Treatment Outcome | 2009 |
Bendamustine hydrochloride in patients with refractory soft tissue sarcoma: a noncomparative multicenter phase 2 study of the German sarcoma group (AIO-001).
Topics: Adolescent; Adult; Aged; Anemia; Antineoplastic Agents; Bendamustine Hydrochloride; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Fever; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Neutropenia; Nitrogen Mustard Compounds; Sarcoma; Treatment Outcome | 2007 |
1 other study(ies) available for bendamustine hydrochloride and Pyrexia
| Article | Year |
|---|---|
Hypersensitivity reactions and drug fever by bendamustine: a case report of three patients.
Topics: Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Drug Hypersensitivity; Female; Fever; Humans; Immunoglobulin E; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Skin; Skin Tests | 2015 |